8-K: Kimberly-Clark Exceeds Expectations in Q1 2024, Raises Full-Year Outlook
Quarterly Report
Kimberly-Clark reported strong first-quarter 2024 results, driven by organic sales growth and productivity gains, leading to an increased full-year outlook.
Summary
- Kimberly-Clark's net sales for the first quarter of 2024 were $5.1 billion, a 1% decrease compared to the prior year, but organic sales grew by 6%.
- The company's gross margin improved significantly to 37.1%, a 390 basis point increase year-over-year, due to organic sales growth and productivity gains.
- Diluted earnings per share (EPS) were $1.91, while adjusted EPS reached $2.01, a 20% increase compared to the prior year, despite a $0.21 headwind from currency translation.
- Organic sales growth was driven by a 4% increase in price, a 1% favorable product mix, and a 1% increase in volume.
- The company has raised its 2024 outlook, now expecting mid-single-digit organic sales growth and low-teens percentage growth in adjusted operating profit and adjusted EPS on a constant-currency basis.
Sentiment
Score: 8
Explanation: The document conveys a positive sentiment due to strong financial results, increased outlook, and management's optimistic tone. The company's performance exceeded expectations, and the raised guidance indicates confidence in future growth.
Positives
- Strong organic sales growth of 6% indicates healthy demand for Kimberly-Clark's products.
- Significant improvement in gross margin by 390 basis points demonstrates effective cost management and pricing strategies.
- Adjusted EPS growth of 20% showcases the company's ability to drive profitability.
- The raised 2024 outlook suggests management's confidence in continued positive performance.
- Positive volume and mix gains across North America and Developing and Emerging markets indicate broad-based strength.
- The company's transformation initiative is showing early signs of success.
Negatives
- Net sales decreased by 1% due to negative impacts from foreign currency translation and divestitures.
- Currency translation had a negative impact of $0.21 on adjusted EPS.
- Reported net sales are expected to be negatively impacted by 400 basis points of currency translation and 120 basis points from divestitures in 2024.
- Cash provided by operations decreased to $438 million from $613 million last year, mainly due to timing differences.
Risks
- The company faces risks from fluctuations in foreign currency exchange rates, particularly in hyperinflationary economies.
- Supply chain disruptions and cost inflation, especially in developing markets, could impact profitability.
- The company's performance is subject to general economic and political conditions globally.
- The company's transformation initiative carries risks related to disruptions to business or operations or delays in implementation.
- The company is exposed to risks related to war in Ukraine and other regional instabilities.
Future Outlook
The company has raised its 2024 outlook, now expecting mid-single-digit organic sales growth and low-teens percentage growth in adjusted operating profit and adjusted EPS on a constant-currency basis. Reported net sales are expected to be negatively impacted by 400 basis points of currency translation and 120 basis points from divestitures.
Management Comments
- We delivered an encouraging set of first quarter results as we embark on this next chapter of growth for Kimberly-Clark, said Kimberly-Clark Chairman and CEO Mike Hsu.
- Im very thankful for the strong execution from our teams around the world who are making this happen.
- Our powerhouse pipeline of innovation drove sequentially stronger gains from volume-plus-mix.
- We continued our strong productivity momentum through our efforts to optimize our margin structure, and we are making good progress focusing our enterprise as we advance the implementation of our new operating model.
- We're excited about our opportunities to capitalize on this momentum on a global level, enabling us to deliver long-term value for our stakeholders.
Industry Context
Kimberly-Clark's strong performance in Q1 2024 reflects a positive trend in the consumer goods sector, where companies are focusing on innovation and productivity to drive growth. The company's ability to achieve organic sales growth and improve margins is a positive sign in a competitive market.
Comparison to Industry Standards
- Procter & Gamble (PG), a major competitor, also reported strong organic sales growth in their recent quarter, indicating a broader trend in the consumer goods industry.
- Kimberly-Clark's 6% organic sales growth is comparable to or slightly better than some of its peers in the personal care and consumer tissue sectors.
- The 390 basis point improvement in gross margin is a significant achievement, suggesting effective cost management compared to industry averages.
- Colgate-Palmolive (CL) and Unilever (UL) are also focusing on productivity and innovation, making Kimberly-Clark's efforts in these areas consistent with industry best practices.
- The company's focus on new product innovation and supply chain optimization aligns with the strategies of other leading consumer goods companies.
Stakeholder Impact
- Shareholders will benefit from increased profitability and a raised outlook.
- Employees are contributing to the company's success through strong execution.
- Customers will benefit from innovative new products.
- The company's sustainable practices support a healthy planet and strong communities.
Next Steps
- The company will continue to implement its transformation initiative.
- Kimberly-Clark will focus on capitalizing on its momentum on a global level.
- The company will host a live Q&A session with investors and analysts on April 23, 2024.
- The company will continue to monitor the macro environment and adjust its outlook as needed.
Key Dates
| Date | Description |
|---|---|
| April 23, 2024 | Date of the earnings release and 8-K filing. |
| March 31, 2024 | End of the first quarter of 2024. |
| June 2023 | Divestiture of the Tissue and K-C Professional business in Brazil. |
Keywords
Kimberly-Clark, organic sales growth, gross margin, earnings per share, adjusted EPS, 2024 outlook, consumer tissue, personal care, K-C Professional, productivity, transformation initiative
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.